SCHEMBL30003540

SCHEMBL30003540

Cc1cc(C(=O)CCc2nc(-c3ccc(Cl)cc3Cl)oc2C(C)C)ccc1OCCO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 5/20 0.55
PPARG P37231 4/20 0.55
PPARD Q03181 4/20 0.55
S1PR3 Q99500 2/20 0.41
HSD17B10 Q99714 2/20 0.40
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
POLB P06746 2/20 0.40
NPC1 O15118 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.37
KDM4E B2RXH2 2/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
ALDH1A1 P00352 1/20 0.36
S1PR1 P21453 1/20 0.36
S1PR5 Q9H228 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24658335 1.00 PPARA (0.55) PPARAPPARGPPARDS1PR3HSD17B10
SCHEMBL24742416 0.94 PPARA (0.50) PPARAPPARGPPARDHSD17B10MAPT
SCHEMBL30004652 0.94 PPARA (0.50) PPARAPPARGPPARDHSD17B10MAPT
SCHEMBL24658330 0.93 PPARG (0.48) PPARAPPARGPPARDS1PR3MAPT
SCHEMBL30003514 0.93 PPARG (0.48) PPARAPPARGPPARDS1PR3MAPT
SCHEMBL12732396 0.92 PPARG (0.57) PPARAPPARGPPARDS1PR3HSD17B10
SCHEMBL2466112 0.92 PPARA (0.54) PPARAPPARGPPARDHSD17B10MAPT
SCHEMBL24658541 0.90 PPARA (0.51) PPARAPPARGPPARDS1PR3HSD17B10
SCHEMBL30003656 0.90 PPARA (0.51) PPARAPPARGPPARDS1PR3HSD17B10
SCHEMBL1765936 0.90 PPARD (0.68) PPARAPPARGPPARDMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333379-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2025-10-30 US disclosed
US-12297168-B2 Compounds useful for treating liver diseases ABIONYX PHARMA SA (FR) 2025-05-13 US disclosed
US-20240199575-A1 COMPOUNDS USEFUL FOR TREATING LIVER DISEASES ABIONYX PHARMA SA (FR) 2024-06-20 US disclosed
US-20230278952-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2023-09-07 US disclosed
US-11634387-B2 Compounds useful for treating liver diseases ABIONYX PHARMA SA (FR) 2023-04-25 US disclosed
US-20220363632-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278952-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARG 71/4885PPARD 332/4885
US-20240199575-A1 COMPOUNDS USEFUL FOR TREATING LIVER DISEASES SLC10A1, FABP1, CPT1A PPARA 94/4885PPARG 71/4885PPARD 332/4885
US-11634387-B2 Compounds useful for treating liver diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARG 71/4885PPARD 332/4885
US-20250333379-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARG 71/4885PPARD 332/4885
US-12297168-B2 Compounds useful for treating liver diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARG 71/4885PPARD 332/4885
US-20220363632-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARA 94/4885PPARG 71/4885PPARD 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.